Relationship between the different replication status of HBV and mutations in the core promoter in mothers and their children infected via mother-to-infant transmission

Hepatobiliary and Pancreatic Diseases International

Volumn 2, Issue 4, 2003, Pages 557-561

  Xu, Hong Mei ^a   Qing, Yu Ling ^a   Peng, Ming Li ^a   Ling, Ning ^a   Ren, Hong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Core promoter; HBV; Mother to infant transmission; Mutation; Replication

Indexed keywords

CORE PROTEIN; NUCLEOTIDE; RESTRICTION ENDONUCLEASE; SERINE PROTEINASE;

ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE TRANSMISSION; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MOLECULAR CLONING; MOTHER; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROMOTER REGION; RECOMBINANT PLASMID; SEQUENCE HOMOLOGY; SEROTYPE; VIRUS REPLICATION;

ADULT; CARRIER STATE; CASE-CONTROL STUDIES; CHILD; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INFANT; MUTATION; POLYMERASE CHAIN REACTION; PREGNANCY; PROBABILITY; PROMOTER REGIONS (GENETICS); REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VIRUS REPLICATION;

EID: 0344012945     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Luo KX. Hepatitis B: basic biology and clinical science. Beijing: People's Medical Publishing House. 1997,161-162.
2. Cheng J, Yang SC. Molecular biology of hepatitis virus. Beijing: People's Military Medical Publisher. 1997,26-28.
3. Lindh M, Andersson AS, Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus: large-scale analysis using a new genotyping method. J Infect Dis 1997;175:1285-1293.
4. Yamaura T, Tanaka E, Matsumoto A, et al. A case-control study for early prediction of hepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter. J Med Virol 2003;70:545-552.
5. Milich DR, Jones JE, Hughes JL, et al. Is a function of the secreted hepatitis B e antigen to induced immunologic tolerance in utero? Proc Acad Sci USA 1990; 87:6599-6603.
6. Romero R, Lavine JE. Cytokine inhibition of the hepatitis B virus core promoter. Hepatology 1996; 23: 17-23.
7. Yotsuyanagi H, Hino K, Tomita E, et al. Precore and core promoter mutations, hepatitis B virus DNA levels and progressive liver injury in chronic hepatitis B. J Hepatol 2002;37:355-363.
8. Shindo M, Hamada K, Koya S, et al. The clinical significance of core promoter and precore mutations during the natural course and interferon therapy in patients with chronic hepatitis B. Am J Gastroenterol 1999;94: 2237-2245.
9. Nagasaka A, Hige S, Marutani M, et al. Prevalence of mutations in the core promoter/precore region in Japanese patients with chronic hepatitis B virus infection. Dig Dis Sci 1998;43:2473-2478.
10. Xing LH, Zhu CL, Shi H, et al. Detection of core promoter mutations in chronic hepatitis B. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2000;14: 163-165.
11. Li J, Buckwold VE, Hon MW, et al. Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation. J Virol 1999;73: 1239-1244.
12. Orito E, Mizokami M, Sakugawa H, et al. A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. Hepatology 2001;33:218-223.
13. Kao JH, Chen PJ, Lai MY, et al. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis. Gastroenterology 2000;118:554-559.
14. Erhardt A, Reineke U, Blondin D, et al. Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B. Hepatology 2000; 31:716-725.